Dimensional Fund Advisors LP Merrimack Pharmaceuticals Inc Transaction History
Dimensional Fund Advisors LP
- $376 Billion
- Q2 2024
A detailed history of Dimensional Fund Advisors LP transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 318,995 shares of MACK stock, worth $4.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
318,995
Previous 398,001
19.85%
Holding current value
$4.83 Million
Previous $5.88 Million
17.9%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MACK
# of Institutions
12Shares Held
437KCall Options Held
0Put Options Held
0-
Jbf Capital, Inc. Aspen, CO39.6KShares$599,7070.1% of portfolio
-
Marshall Wace, LLP London, X038.2KShares$578,2830.0% of portfolio
-
Goldman Sachs Group Inc New York, NY29.8KShares$450,9790.0% of portfolio
-
Caldwell Sutter Capital, Inc. Sausalito, CA7.46KShares$112,8390.0% of portfolio
-
Rhumbline Advisers Boston, MA2.48KShares$37,5220.0% of portfolio
About MERRIMACK PHARMACEUTICALS INC
- Ticker MACK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,410,200
- Market Cap $203M
- Description
- Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.